AKASA
Generative AI that autonomously codes inpatient encounters and optimizes the hospital revenue cycle.
By AKASA, Inc. · 4.0/5 Value-Position score (estimate)
Positioning guardrails
Best for
- Health systems with large inpatient volumes and chronic coding/CDI backlogs
- Revenue cycle leaders targeting faster-to-bill encounters and cleaner claims
- Provider organizations willing to tune a model on their own documentation and payer rules
Ideal size: Enterprise (500+ hospital beds) people · Health system with an established RCM and CDI function
Not for
- Independent physician practices or outpatient-only clinics
- Small revenue cycle teams without the documentation volume to justify a custom model
- Buyers who need published, self-serve pricing or a fast DIY setup
Value metrics scorecard
Time-to-Value
Roughly 2-4 months (enterprise rollout)
~90 days to first production value
Total Cost of Ownership
On request
Custom enterprise pricing; no rates published on the vendor site
Implementation Friction
4/5
Engineering + admin effort required
Value-Position score
out of 5 · model estimate
Full cost breakdown
Mandatory implementation fee
None
Seat tiers
Not listed
Add-on costs
- None
Company & support
Who is behind AKASA, and how your team gets help once it is live.
Market position
Where AKASA sits against its closest alternatives. Pick any two of cost, speed, friction and buyer score, and up to 9 companies to compare.
Quadrant view
Typical annual cost × Time-to-value
The lines cross at the median of the solutions shown, so about half sit on each side of each line. A dashed ring marks an outlier pinned to the edge; hover for its value.
Companies on the chart 6 / 10
- AKASA
- Nym
- CodaMetrix
- Hello Patient
- Waystar
- Adonis
Add or change companies
Up to 10 companies including AKASA. Listed closest first.
Stack fit signal
Compatibility with standard B2B ecosystems.
No supported MCP path today, so it cannot be driven from an AI client.
AI & MCP readiness
What AKASA ships in AI, and what it asks of your ecosystem.
AI features shipped
Vendor pages describe autonomous inpatient coding that reads and reasons across the complete patient record, GenAI optimizers for prebill, coding and CDI work, an AI research assistant (AI Advisor), and automated authorization and claim status checks. No reviewed page documents model key handling, per-action AI logging, or AI-specific pricing.
Your data & models
- Trains on your data
- Not recorded — ask the vendor
- Runs on
- Not recorded
- AI pricing
- Not recorded
In your ecosystem
- AI connection
- Not supported
- Model key
- Not recorded
- AI usage audit
- Not recorded
Compliance attestations
* IAPP AIGP certifies individuals, not products. It means named staff hold the credential — not that the platform does.
Bottom line
AKASA applies generative AI to the healthcare revenue cycle: autonomous inpatient coding plus prebill optimization, coding and CDI optimizers, an AI advisor, and automated authorization and claim status checks. It builds a custom model per health system, trained on that system's documentation, case mix and coding decisions, and reports 500 hospital clients representing one in ten US inpatient discharges. Expect an enterprise sales cycle, custom model onboarding and no published pricing.
Frequently asked questions
What does AKASA actually automate?
AKASA's core offer is autonomous inpatient coding: it reads the complete patient record, applies the health system's coding standards and codes the encounter with evidence behind every code. Alongside that it sells a Prebill Optimization Suite, Coding Optimizer, CDI Optimizer, an AI research assistant (AI Advisor), and automated authorization and claim status checking. The vendor says 65 to 85 percent of inpatient volume at most health systems is autonomously addressable, with the threshold set by each customer's own case mix and quality standards.
How accurate is the autonomous coding, and who is accountable for the final code?
The vendor states its coding has matched or exceeded expert coder accuracy in a blinded third-party evaluation across entire code sets, and that customers set the threshold for autonomous volume. Because the model is tuned to your documentation and payer rules, accuracy claims are customer-specific; buyers should insist on a validation period against their own audit results before expanding autonomous volume.
How long does implementation take and what does it require?
AKASA builds a custom AI model for each health system, trained on that organization's clinical documentation, case mix and coding decisions. That is a configuration-heavy onboarding rather than a self-serve setup: expect data access, model tuning and clinical validation work, typically measured in months, before autonomous coding reaches steady-state volume. No implementation timeline or fee is published on the vendor site.
How is AKASA priced?
AKASA does not publish prices, seat tiers or implementation fees; the site routes buyers to a sales conversation. Treat it as custom enterprise pricing and ask for the pricing model, implementation fee, per-encounter or per-volume components, and any add-on charges for the separate optimizers and advisor modules in the proposal.
Is our patient data used to train AKASA's models?
AKASA's site states that it builds a custom AI model for your health system trained on your own clinical documentation, case mix and coding decisions, which means customer content is used in model training. The reviewed privacy notice excerpt does not describe a general opt-out or specify retention and deletion terms, so data-use, de-identification and retention commitments should be negotiated explicitly in the business associate agreement before go-live.